Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease

OBJECTIVES: To compare the net clinical benefit of oral anticoagulant (OAC) monotherapy to OAC plus single antiplatelet therapy (SAPT) in patients with atrial fibrillation (AF) and stable coronary artery disease (CAD) at 1- and 3-year after percutaneous coronary intervention (PCI). BACKGROUND: It ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, So-Ryoung, Jung, Jin-Hyung, Choi, Eue-Keun, Lee, Seung-Woo, Kwon, Soonil, Park, Ji-Suck, Kang, Jeehoon, Han, Kyung-Do, Park, Kyung Woo, Oh, Seil, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441665/
https://www.ncbi.nlm.nih.gov/pubmed/36072876
http://dx.doi.org/10.3389/fcvm.2022.991293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441665/
https://www.ncbi.nlm.nih.gov/pubmed/36072876
http://dx.doi.org/10.3389/fcvm.2022.991293

Ejemplares similares